Illicium verum anticancer activity against MDA-MB-231 cell line

Area of Science:

• Pharmacology
• Oncology
• Natural Products Chemistry

Background:

• Triple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted therapies.
• Illicium verum (star anise) is a spice with a history of traditional medicinal uses.
• Investigating natural compounds for novel anticancer agents is crucial.

Purpose of the Study:

• To evaluate the anticancer potential of the methanolic extract of Illicium verum.
• To assess its effects on the proliferation and viability of MDA-MB-231 cells, a model for TNBC.
• To determine if the extract induces apoptosis in cancer cells.

Main Methods:

• The study utilized a cell culture model involving MDA-MB-231 cells.
• Cell viability and proliferation were quantified using tetrazolium assays and an enzyme immunosorbent plate reader.
• Apoptosis initiation was assessed by fluorescent staining and observation.

Main Results:

• All tested doses of Illicium verum methanolic extract significantly reduced MDA-MB-231 cell viability (p < 0.01).
• The half maximal inhibitory concentration (IC50) dose of 2.8µg/ml significantly inhibited cell proliferation (p < 0.01).
• The IC50 dose also significantly induced apoptosis in MDA-MB-231 cells (p < 0.01).

Conclusions:

• Methanolic extract of Illicium verum exhibits potent anticancer activity against triple-negative breast cancer.
• The extract functions through mechanisms including cytotoxicity, reduction of proliferation, and induction of apoptosis.
• Illicium verum represents a potential source for developing novel therapeutic strategies for TNBC.